Effectively managing malignancy in patients with Inflammatory Bowel Disease (IBD) requires a comprehensive and proactive approach. The latest guidance from the American Gastroenterological Association (AGA) offers valuable strategies for healthcare providers. What are the essential practices recommended to address malignancy in IBD, and how can they improve patient outcomes?
Questions about how to manage malignancy in your IBD patients? Our experts have answers (AGA)
0